TY - JOUR
T1 - Image-guided breast biopsy and localisation
T2 - recommendations for information to women and referring physicians by the European Society of Breast Imaging
AU - Bick, Ulrich
AU - Trimboli, Rubina M
AU - Athanasiou, Alexandra
AU - Balleyguier, Corinne
AU - Baltzer, Pascal A T
AU - Bernathova, Maria
AU - Borbély, Krisztina
AU - Brkljacic, Boris
AU - Carbonaro, Luca A
AU - Clauser, Paola
AU - Cassano, Enrico
AU - Colin, Catherine
AU - Esen, Gul
AU - Evans, Andrew
AU - Fallenberg, Eva M
AU - Fuchsjaeger, Michael H
AU - Gilbert, Fiona J
AU - Helbich, Thomas H
AU - Heywang-Köbrunner, Sylvia H
AU - Herranz, Michel
AU - Kinkel, Karen
AU - Kilburn-Toppin, Fleur
AU - Kuhl, Christiane K
AU - Lesaru, Mihai
AU - Lobbes, Marc B I
AU - Mann, Ritse M
AU - Martincich, Laura
AU - Panizza, Pietro
AU - Pediconi, Federica
AU - Pijnappel, Ruud M
AU - Pinker, Katja
AU - Schiaffino, Simone
AU - Sella, Tamar
AU - Thomassin-Naggara, Isabelle
AU - Tardivon, Anne
AU - Ongeval, Chantal Van
AU - Wallis, Matthew G
AU - Zackrisson, Sophia
AU - Forrai, Gabor
AU - Herrero, Julia Camps
AU - Sardanelli, Francesco
N1 - Funding Information:
IT-N was in the speakers’ bureau for Guerbet, Canon, General Electric, Hologic, and Samsung and was member of advisory board for Siemens and Bard. KP does not declare competing interests with the article topic; outside the article topic, she declares funding by the NIH/NCI Cancer Center Support Grant P30 CA008748, Digital Hybrid Breast PET/MRI for Enhanced Diagnosis of Breast Cancer (HYPMED), H2020—Research and Innovation Framework Programme PHC-11-2015 # 667211-2, A Body Scan for Cancer Detection using Quantum Technology (CANCERSCAN), H2020-FETOPEN-2018-2019-2020-01 # 828978, Multiparametric 18F-Fluoroestradiol PET/MRI coupled with Radiomics Analysis and Machine Learning for Prediction and Assessment of Response to Neoadjuvant Endocrine Therapy in Patients with Hormone Receptor+/HER2− Invasive Breast Cancer 02.09.2019/31.08.2020 # Nr: 18207, Jubiläumsfonds of the Austrian National Bank. SS was in the speakers’ bureau for General Electric. SZ was in the speakers’ bureau for Siemens Healthcare AG. FS was in the speakers’ bureau for Bayer Healthcare, Bracco, and General Electric, was member of advisory board for Bracco, and General Electric, and received research grants from Bayer Healthcare, Bracco, and General Electric. The other authors declare that they have no competing interests.
Publisher Copyright:
© 2020, The Author(s).
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/12/1
Y1 - 2020/12/1
N2 - We summarise here the information to be provided to women and referring physicians about percutaneous breast biopsy and lesion localisation under imaging guidance. After explaining why a preoperative diagnosis with a percutaneous biopsy is preferred to surgical biopsy, we illustrate the criteria used by radiologists for choosing the most appropriate combination of device type for sampling and imaging technique for guidance. Then, we describe the commonly used devices, from fine-needle sampling to tissue biopsy with larger needles, namely core needle biopsy and vacuum-assisted biopsy, and how mammography, digital breast tomosynthesis, ultrasound, or magnetic resonance imaging work for targeting the lesion for sampling or localisation. The differences among the techniques available for localisation (carbon marking, metallic wire, radiotracer injection, radioactive seed, and magnetic seed localisation) are illustrated. Type and rate of possible complications are described and the issue of concomitant antiplatelet or anticoagulant therapy is also addressed. The importance of pathological-radiological correlation is highlighted: when evaluating the results of any needle sampling, the radiologist must check the concordance between the cytology/pathology report of the sample and the radiological appearance of the biopsied lesion. We recommend that special attention is paid to a proper and tactful approach when communicating to the woman the need for tissue sampling as well as the possibility of cancer diagnosis, repeat tissue sampling, and or even surgery when tissue sampling shows a lesion with uncertain malignant potential (also referred to as "high-risk" or B3 lesions). Finally, seven frequently asked questions are answered.
AB - We summarise here the information to be provided to women and referring physicians about percutaneous breast biopsy and lesion localisation under imaging guidance. After explaining why a preoperative diagnosis with a percutaneous biopsy is preferred to surgical biopsy, we illustrate the criteria used by radiologists for choosing the most appropriate combination of device type for sampling and imaging technique for guidance. Then, we describe the commonly used devices, from fine-needle sampling to tissue biopsy with larger needles, namely core needle biopsy and vacuum-assisted biopsy, and how mammography, digital breast tomosynthesis, ultrasound, or magnetic resonance imaging work for targeting the lesion for sampling or localisation. The differences among the techniques available for localisation (carbon marking, metallic wire, radiotracer injection, radioactive seed, and magnetic seed localisation) are illustrated. Type and rate of possible complications are described and the issue of concomitant antiplatelet or anticoagulant therapy is also addressed. The importance of pathological-radiological correlation is highlighted: when evaluating the results of any needle sampling, the radiologist must check the concordance between the cytology/pathology report of the sample and the radiological appearance of the biopsied lesion. We recommend that special attention is paid to a proper and tactful approach when communicating to the woman the need for tissue sampling as well as the possibility of cancer diagnosis, repeat tissue sampling, and or even surgery when tissue sampling shows a lesion with uncertain malignant potential (also referred to as "high-risk" or B3 lesions). Finally, seven frequently asked questions are answered.
KW - Breast
KW - Breast lesion localisation
KW - Core needle biopsy
KW - Fine-needle sampling
KW - Vacuum-assisted biopsy
UR - http://www.scopus.com/inward/record.url?scp=85079157532&partnerID=8YFLogxK
U2 - 10.1186/s13244-019-0803-x
DO - 10.1186/s13244-019-0803-x
M3 - Article
C2 - 32025985
SN - 1869-4101
VL - 11
JO - Insights into Imaging
JF - Insights into Imaging
IS - 1
M1 - 12
ER -